geraldine's whisper

This one's waking up a little.

I had it on a watchlist after an institutional manager mentioned it to me as being of interest a few months back. Primary reason for having interest is that it's been trading pretty much in line with cash backing. . . . . .so if there's any value in the technology it should be a good punt.

I had a talented cancer scientist review the technology, the data and the IP for me today. . . . and he like what he sees. Admittedly, the data is all in mouse models at this stage, but he thought there was a solid chance that this data would be predictive of good success in human trials.

Anyway - have a read of the presentation from earlier in the week.

Worth a punt, but it's a five year hold for a 10x return if things go well.